This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

China Stocks: Price vs. Fundamentals

Stocks in this article: CWS BSPM DYP

Along with Orient Paper (ONP - Get Report), my favorite price vs. fundamentals play is Duoyuan Printing (DYP). DYP traded down to an almost absurd level of $7.84 when the market had its mini meltdown. But similar to China Wind Systems, DYP announced results that significantly beat expectations on a day when the market was rebounding, in a rally fueled by European stimulus money. As a result the stock leaped by over 25% in 2 days to as high as $9.74 on significant volume. I was gobbling up shares below $8 while I could and continued buying up into the $8-9 range.

Despite the rapid jump in the share price I didn't sell a single share for two reasons. First, I think the stock has room to run by about another 50%. Second, the fundamentals are so strong that even if it trades down I don't lose any sleep over it. This is my safety stock. DYP has a market cap of $280 million, but has $140 million in cash and receivables on its balance sheet. Cash flow from operations in the first quarter alone was nearly $20 million. The company beat revenue guidance by a wide margin and continues to enjoy gross margins of more than 50%. Revenues grew by 34% vs. last year. In terms of valuation, in the $9-$10 range, the company trades at less than eight times earnings, despite being a NYSE listed stock with huge growth and margins. In the past I have compared this for valuation purposes to Duoyuan Global Water (DGW) which has slightly less attractive fundamentals and yet trades on 3-4 times the earnings multiple. DGW and DYP are both run by the same chairman and have similar fundamentals and I feel that the valuation discrepancy makes DYP an easy choice at current levels.

Biostar Pharmaceuticals (BSPM - Get Report) has turned out to be a case of snatching defeat from the jaws of victory. I correctly picked this one out at just under $4 and noted that the $4 threshold share price was the only thing holding BSPM back from its uplisting. Sure enough, seven trading days after reaching $4, the stock uplisted and shot as high as $5.50 - a 38% run in a few days. What followed was a perfect storm of negative events.

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs